We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

52 hedge funds and large institutions have $142M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

10% more capital invested

Capital invested by funds: $130M → $142M (+$12.6M)

8% more funds holding

Funds holding: 48 → 52 (+4)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

Holders
52
Holders Change
+4
Holders Change %
+8.33%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$4.83M
2
GCL
Glazer Capital LLC
New York
+$3.71M
3
Calamos Advisors
Calamos Advisors
Illinois
+$3.68M
4
AC
Aristeia Capital
Connecticut
+$2.45M
5
Millennium Management
Millennium Management
New York
+$1.19M

Top Sellers

Rank Fund Capital Flow
1
KC
Kepos Capital
New York
-$4.87M
2
PC
Periscope Capital
Ontario, Canada
-$1.26M
3
ACA
Arena Capital Advisors
California
-$1.08M
4
HighTower Advisors
HighTower Advisors
Illinois
-$706K
5
BCM
Basso Capital Management
Connecticut
-$488K
Name Holding Trade Value Shares
Change 		Change in
Stake
6CM
1
683 Capital Management
New York
$11.8M – – –
FTCM
2
Fir Tree Capital Management
New York
$9.4M +$27.5K +2,800 +0.3%
KL
3
KIM LLC
Kansas
$7.89M – – –
MI
4
MMCAP International
Cayman Islands
$7.87M – – –
CF
5
Cantor Fitzgerald
New York
$6.79M – – –
HSBC Holdings
6
HSBC Holdings
United Kingdom
$6.49M – – –
CSS
7
Cubist Systematic Strategies
Connecticut
$6.24M -$1.43K -146 -0%
Millennium Management
8
Millennium Management
New York
$5.49M +$1.19M +120,819 +28%
MF
9
Magnetar Financial
Illinois
$5.08M +$4.83M +492,000 +2,165%
ACM
10
Atalaya Capital Management
New York
$4.93M – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
11
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$4.93M – – –
PSAMP
12
P. Schoenfeld Asset Management (PSAM)
New York
$4.93M – – –
PC
13
Periscope Capital
Ontario, Canada
$4.64M -$1.26M -127,929 -21%
GCL
14
Glazer Capital LLC
New York
$4.39M +$3.71M +378,460 +562%
HighTower Advisors
15
HighTower Advisors
Illinois
$4.09M -$706K -72,000 -15%
RCM
16
Radcliffe Capital Management
Pennsylvania
$4.05M +$294 +30 +0%
Calamos Advisors
17
Calamos Advisors
Illinois
$3.7M +$3.68M +375,000 New
AGC
18
Angelo Gordon & Co
New York
$2.95M – – –
Marshall Wace
19
Marshall Wace
United Kingdom
$2.92M +$205K +20,911 +8%
SC
20
Sculptor Capital
New York
$2.46M – – –
AC
21
Aristeia Capital
Connecticut
$2.46M +$2.45M +250,000 New
UOC
22
UBS O'Connor
Illinois
$2.34M -$233K -23,795 -9%
SCM
23
Shaolin Capital Management
Florida
$2.18M – – –
AA
24
AQR Arbitrage
Connecticut
$1.97M – – –
TCA
25
Taconic Capital Advisors
New York
$1.92M – – –
1
2 3

ORIA Hedge Fund Activity: Q3 2022 in Review

52 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q3 2022, worth a combined $142M — up 9.7% from $130M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ORIA positions and 3 closed out — a net gain of 5 holders — while 8 added to existing stakes and 9 trimmed.

The largest buyer was Magnetar Financial, adding an estimated $4.83M. The largest seller was Kepos Capital, exiting entirely with an estimated $4.87M sold.

  • 52 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q3 2022, up from 48 in Q2 2022.
  • Funds reported $142M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q3 2022, up 9.7% quarter-over-quarter.
  • 8 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q3 2022 and 3 closed out, a net change of +5 holders.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q3 2022 was Magnetar Financial, an estimated $4.83M added.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q3 2022 was Kepos Capital, an estimated $4.87M sold.

Based on aggregated 13F filings for Q3 2022.